Site icon fundsforNGOs

The Africa CDC Launches Short-Course Trainings in Vaccine Manufacturing

The Africa CDC Launches Short-Course Trainings in Vaccine Manufacturing

Deadline: 31-Mar-23

The Partnerships for African Vaccine Manufacturing (PAVM) is proud to announce the second sponsored short course, in partnership with Biomedical Advanced Research and Development Authority (BARDA).

This will include sponsorship for 24 vaccine manufacturing professionals to complete four short courses at the Texas A&M National Center for Therapeutics Manufacturing in College Station, Texas.

A key pillar of this mandate seeks to expand the local manufacture of vaccines, diagnostics, and therapeutics. Less than one percent of vaccines administered on the continent are manufactured locally. The PAVM was established by the AU, under the Africa CDC, in 2021 to deliver a bold goal: enabling the African vaccine manufacturing industry to develop, produce, and supply over 60 percent of the total vaccine doses required on the continent by 2040.

Scaling vaccine manufacturing and R&D across the continent to meet the AU’s 2040 ambitions will require quadrupling the vaccine workforce to approximately 12,500 full-time employees (FTEs). To respond to the immediate vaccine manufacturing talent needs and actualize the short-term vision, Africa CDC in collaboration with Texas A & M University National Centre for Therapeutics Manufacturing (NCTM) is organizing short-term course trainings relevant to biopharmaceutical manufacturing.

Financing

The selected candidates will be fully funded by the Africa CDC with the support of the Biomedical Advanced Research and Development Authority (BARDA) of the United States of America. The funding includes:

Overview of Africa CDC and BARDA-sponsored Texas A&M courses
Eligibility criteria for the short-course trainings.
Selection process

The Africa CDC PAVM will set up a committee to review all applications, and only those selected will be contacted for further processes. Only 24 candidates will be selected.

For more information, visit Africa CDC.

Exit mobile version